Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/39939
Title: Pharmacist provided medicines reconciliation within 24 hours of admission and on discharge: a randomised controlled pilot study
Authors: Cadman, Brit
Wright, David
Bale, Amanda
Barton, Garry
Desborough, James
Hammad, Eman A.
Holland, Richard
Howe, Helen
Nunney, Ian
Irvine, Lisa
First Published: 1-Mar-2017
Publisher: BMJ Publishing Group
Citation: BMJ Open, 2017, 7:e013647
Abstract: Background: The UK government currently recommends that all patients receive medicines reconciliation (MR) from a member of the pharmacy team within 24 hours of admission and subsequent discharge. The cost-effectiveness of this intervention is unknown. A pilot study to inform the design of a future randomised controlled trial to determine effectiveness and cost-effectiveness of a pharmacist-delivered service was undertaken. Method: Patients were recruited 7 days a week from 5 adult medical wards in 1 hospital over a 9 month period and randomised using an automated system to intervention (MR within 24 hours of admission and at discharge) or usual care which may include MR (control). Recruitment and retention rates were determined. Length of stay (LOS), quality of life (EQ-5D-3L), unintentional discrepancies (UDs) and emergency readmission (ER) within 3 months were tested as outcome measures. The feasibility of identifying and measuring intervention-associated resources was determined. Result: 200 patients were randomised to either intervention or control. Groups were comparable at baseline. 95 (99%) patients in the intervention received MR within 24 hours, while 62 (60.8%) control patients received MR at some point during admission. The intervention resolved 250 of the 255 UDs identified at admission. Only 2 UDs were identified in the intervention group at discharge compared with 268 in the control. The median LOS was 94 hours in the intervention arm and 118 hours in the control, with ER rates of 17.9% and 26.7%, respectively. Assuming 5% loss to follow-up 1120 patients (560 in each arm) are required to detect a 6% reduction in 3-month ER rates. Conclusions: The results suggest that changes in outcome measures resulting from MR within 24 hours were in the appropriate direction and readmission within 3 months is the most appropriate primary outcome measure. A future study to determine cost-effectiveness of the intervention is feasible and warranted.
DOI Link: 10.1136/bmjopen-2016-013647
ISSN: 2044-6055
eISSN: 2044-6055
Links: http://bmjopen.bmj.com/content/7/3/e013647
http://hdl.handle.net/2381/39939
Version: Publisher Version
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © the authors, 2017. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Appears in Collections:Published Articles, Dept. of Medical and Social Care Education

Files in This Item:
File Description SizeFormat 
e013647.full.pdfPublished (publisher PDF)1.15 MBAdobe PDFView/Open


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.